Supernus Pharmaceuticals | SUPN - Ebit


Supernus Pharmaceuticals reported $13.82M in EBIT for its fiscal quarter ending in December of 2025.





Ebit Change Date
Abbott USD 2.54B 358M Dec/2025
ANI Pharmaceuticals USD 29.13M 6.3M Dec/2025
Aurora Cannabis CAD -44.75M 27.14M Sep/2025
Bristol-Myers Squibb USD 3.47B 567M Dec/2025
Canopy Growth CAD -14.3M 17.19M Sep/2025
Cara Therapeutics USD -2.39M 3.16M Mar/2025
Corcept Therapeutics USD 4.49M 5.73M Dec/2025
Eisai JPY 20.03B 6.36B Dec/2025
Eli Lilly USD 8.99B 1.57B Dec/2025
Novo Nordisk DKK 32.38B 1.7B Dec/2025
Pacira USD 3.19M 9.96M Dec/2025
Perrigo USD 84.4M 9M Dec/2025
Pfizer USD 4.65B 71M Dec/2025
Supernus Pharmaceuticals USD 13.82M 74.01M Dec/2025
United Therapeutics USD -14.6M 403.9M Dec/2025
Xeris Pharmaceuticals USD 7.89M 2.46M Sep/2025